NCT04268680

Brief Summary

Gait analysis is a quick and powerful tool with a wide range of clinical applications in various fields. However, due to the expensive and highly specialized equipment required, gait studies are mostly limited to academic research centers and small sample sizes and no large-scale, randomized controlled trials have been performed. Several authors have proposed inexpensive accelerometer-based systems to remedy this situation. Through mathematic transformation they adequately measure step time and length. With these systems however only temporal spatial gait parameters can be recorded; kinetic gait parameters, such as ground reaction force, cannot be measured. As these kinetic parameters are important for clinical studies, especially in fracture and rehabilitation research different methods are needed. Its availability is mainly limited to research centers, conventional gait analysis is further hindered by its stationarity and that it only allows momentary views of the patient's gait in a confined research environment. Even smaller, wearable systems have to be attached to an external apparatus, or are limited by their battery capacity, data storage and other device specific factors. Furthermore, the use of these systems is at an early clinical stage and their full potential not yet developed. As most disease processes are continuous, tools with long-term, continuous measuring capabilities are needed. For this reason a new pressure-measuring insole with built in battery and data storage was developed in cooperation with the AO Foundation(AO Foundation, Davos, Switzerland). The system offers complete independence from any external measures for up to 4 weeks and monitors a patient step during this time. The purpose of this pilot study is to investigate which how TKA arthroplasty may impact gait during early and medium term rehabilitation phase. This will be done through the use of the OpenGo Sensor Insole (Moticon GmbH).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 9, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 8, 2018

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

February 11, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 13, 2020

Completed
Last Updated

April 24, 2020

Status Verified

February 1, 2020

Enrollment Period

2 months

First QC Date

February 11, 2020

Last Update Submit

April 22, 2020

Conditions

Keywords

gait cycleknee arthroplastywearable insole

Outcome Measures

Primary Outcomes (1)

  • Perioperative Case Series: clinical evaluation of gait cycle and ground in Knee arthroplasty patients

    Evaluation of gait cycle and ground in primary TKA patients compared to the healthy contralateral limb.

    baseline to 3 month

Secondary Outcomes (1)

  • Perioperative Case Series: qualitative evaluation of gait cycle and ground in Knee arthroplasty patients

    baseline to 3 month

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients affected by degenerative gonarthrosis who need a TKA in one of the two Knees

You may qualify if:

  • primary TKA
  • years of age (included)
  • skeletally mature
  • willing and able to participate in required pre-op and follow-up visits at the investigational site and to complete study procedures and questionnaires
  • consented to participating in the study by signing the IRB/EC approved informed consent form
  • BMI \<32

You may not qualify if:

  • symptomatic/debilitating co-commitant arthropathy of non-operative joints (e.g. a TKA patient cannot have advanced arthritis of the contralateral knee or ipsilateral hip/ankle) that would impede or otherwise confuse the peri-operative measurement of gait.
  • Significant comorbidities that would impede the patients ability to participate in standard recovery and rehabilitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituto Ortopedico Galeazzi

Milan, 20161, Italy

Location

MeSH Terms

Conditions

Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Michele Ulivi, Dr

    IRCCS Istituto Ortopedico GaleazziMilano

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2020

First Posted

February 13, 2020

Study Start

November 7, 2017

Primary Completion

January 9, 2018

Study Completion

June 8, 2018

Last Updated

April 24, 2020

Record last verified: 2020-02

Locations